nodes	percent_of_prediction	percent_of_DWPC	metapath
Iohexol—Urticaria—Prednisolone—hematologic cancer	0.000189	0.000189	CcSEcCtD
Iohexol—Cardiac disorder—Methotrexate—hematologic cancer	0.000189	0.000189	CcSEcCtD
Iohexol—Urinary tract disorder—Epirubicin—hematologic cancer	0.000188	0.000188	CcSEcCtD
Iohexol—Rash—Vincristine—hematologic cancer	0.000188	0.000188	CcSEcCtD
Iohexol—Dermatitis—Vincristine—hematologic cancer	0.000188	0.000188	CcSEcCtD
Iohexol—Pain—Triamcinolone—hematologic cancer	0.000187	0.000187	CcSEcCtD
Iohexol—Urethral disorder—Epirubicin—hematologic cancer	0.000187	0.000187	CcSEcCtD
Iohexol—Headache—Vincristine—hematologic cancer	0.000187	0.000187	CcSEcCtD
Iohexol—Loss of consciousness—Prednisone—hematologic cancer	0.000186	0.000186	CcSEcCtD
Iohexol—Hypotension—Dexamethasone—hematologic cancer	0.000186	0.000186	CcSEcCtD
Iohexol—Hypotension—Betamethasone—hematologic cancer	0.000186	0.000186	CcSEcCtD
Iohexol—Nausea—Carmustine—hematologic cancer	0.000185	0.000185	CcSEcCtD
Iohexol—Angiopathy—Methotrexate—hematologic cancer	0.000185	0.000185	CcSEcCtD
Iohexol—Vomiting—Irinotecan—hematologic cancer	0.000184	0.000184	CcSEcCtD
Iohexol—Vomiting—Mitoxantrone—hematologic cancer	0.000184	0.000184	CcSEcCtD
Iohexol—Immune system disorder—Methotrexate—hematologic cancer	0.000184	0.000184	CcSEcCtD
Iohexol—Nausea—Alitretinoin—hematologic cancer	0.000184	0.000184	CcSEcCtD
Iohexol—Convulsion—Prednisone—hematologic cancer	0.000184	0.000184	CcSEcCtD
Iohexol—Mediastinal disorder—Methotrexate—hematologic cancer	0.000183	0.000183	CcSEcCtD
Iohexol—Hypertension—Prednisone—hematologic cancer	0.000183	0.000183	CcSEcCtD
Iohexol—Rash—Mitoxantrone—hematologic cancer	0.000183	0.000183	CcSEcCtD
Iohexol—Rash—Irinotecan—hematologic cancer	0.000183	0.000183	CcSEcCtD
Iohexol—Dermatitis—Mitoxantrone—hematologic cancer	0.000183	0.000183	CcSEcCtD
Iohexol—Dermatitis—Irinotecan—hematologic cancer	0.000183	0.000183	CcSEcCtD
Iohexol—Headache—Mitoxantrone—hematologic cancer	0.000182	0.000182	CcSEcCtD
Iohexol—Headache—Irinotecan—hematologic cancer	0.000182	0.000182	CcSEcCtD
Iohexol—Nausea—Ifosfamide—hematologic cancer	0.000181	0.000181	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.000181	0.000181	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.000181	0.000181	CcSEcCtD
Iohexol—Arthralgia—Prednisone—hematologic cancer	0.00018	0.00018	CcSEcCtD
Iohexol—Feeling abnormal—Triamcinolone—hematologic cancer	0.00018	0.00018	CcSEcCtD
Iohexol—Diarrhoea—Cisplatin—hematologic cancer	0.00018	0.00018	CcSEcCtD
Iohexol—Vomiting—Gemcitabine—hematologic cancer	0.00018	0.00018	CcSEcCtD
Iohexol—Bradycardia—Doxorubicin—hematologic cancer	0.000179	0.000179	CcSEcCtD
Iohexol—Paraesthesia—Dexamethasone—hematologic cancer	0.000178	0.000178	CcSEcCtD
Iohexol—Paraesthesia—Betamethasone—hematologic cancer	0.000178	0.000178	CcSEcCtD
Iohexol—Discomfort—Prednisone—hematologic cancer	0.000178	0.000178	CcSEcCtD
Iohexol—Mental disorder—Methotrexate—hematologic cancer	0.000178	0.000178	CcSEcCtD
Iohexol—Rash—Gemcitabine—hematologic cancer	0.000178	0.000178	CcSEcCtD
Iohexol—Dermatitis—Gemcitabine—hematologic cancer	0.000178	0.000178	CcSEcCtD
Iohexol—Eye disorder—Epirubicin—hematologic cancer	0.000178	0.000178	CcSEcCtD
Iohexol—Hypersensitivity—Etoposide—hematologic cancer	0.000178	0.000178	CcSEcCtD
Iohexol—Erythema—Methotrexate—hematologic cancer	0.000177	0.000177	CcSEcCtD
Iohexol—Headache—Gemcitabine—hematologic cancer	0.000177	0.000177	CcSEcCtD
Iohexol—Nausea—Vincristine—hematologic cancer	0.000177	0.000177	CcSEcCtD
Iohexol—Flushing—Epirubicin—hematologic cancer	0.000177	0.000177	CcSEcCtD
Iohexol—Cardiac disorder—Epirubicin—hematologic cancer	0.000177	0.000177	CcSEcCtD
Iohexol—Hypersensitivity—Prednisolone—hematologic cancer	0.000175	0.000175	CcSEcCtD
Iohexol—Urinary tract disorder—Doxorubicin—hematologic cancer	0.000174	0.000174	CcSEcCtD
Iohexol—Urticaria—Triamcinolone—hematologic cancer	0.000174	0.000174	CcSEcCtD
Iohexol—Dysgeusia—Methotrexate—hematologic cancer	0.000173	0.000173	CcSEcCtD
Iohexol—Body temperature increased—Triamcinolone—hematologic cancer	0.000173	0.000173	CcSEcCtD
Iohexol—Anaphylactic shock—Prednisone—hematologic cancer	0.000173	0.000173	CcSEcCtD
Iohexol—Angiopathy—Epirubicin—hematologic cancer	0.000173	0.000173	CcSEcCtD
Iohexol—Urethral disorder—Doxorubicin—hematologic cancer	0.000173	0.000173	CcSEcCtD
Iohexol—Nausea—Mitoxantrone—hematologic cancer	0.000172	0.000172	CcSEcCtD
Iohexol—Nausea—Irinotecan—hematologic cancer	0.000172	0.000172	CcSEcCtD
Iohexol—Immune system disorder—Epirubicin—hematologic cancer	0.000172	0.000172	CcSEcCtD
Iohexol—Mediastinal disorder—Epirubicin—hematologic cancer	0.000172	0.000172	CcSEcCtD
Iohexol—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000171	0.000171	CcSEcCtD
Iohexol—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000171	0.000171	CcSEcCtD
Iohexol—Pruritus—Etoposide—hematologic cancer	0.000171	0.000171	CcSEcCtD
Iohexol—Shock—Prednisone—hematologic cancer	0.00017	0.00017	CcSEcCtD
Iohexol—Arrhythmia—Epirubicin—hematologic cancer	0.00017	0.00017	CcSEcCtD
Iohexol—Pain—Dexamethasone—hematologic cancer	0.00017	0.00017	CcSEcCtD
Iohexol—Pain—Betamethasone—hematologic cancer	0.00017	0.00017	CcSEcCtD
Iohexol—Nervous system disorder—Prednisone—hematologic cancer	0.00017	0.00017	CcSEcCtD
Iohexol—Skin disorder—Prednisone—hematologic cancer	0.000168	0.000168	CcSEcCtD
Iohexol—Nausea—Gemcitabine—hematologic cancer	0.000168	0.000168	CcSEcCtD
Iohexol—Vomiting—Cisplatin—hematologic cancer	0.000167	0.000167	CcSEcCtD
Iohexol—Mental disorder—Epirubicin—hematologic cancer	0.000167	0.000167	CcSEcCtD
Iohexol—Rash—Cisplatin—hematologic cancer	0.000166	0.000166	CcSEcCtD
Iohexol—Dermatitis—Cisplatin—hematologic cancer	0.000166	0.000166	CcSEcCtD
Iohexol—Erythema—Epirubicin—hematologic cancer	0.000166	0.000166	CcSEcCtD
Iohexol—Diarrhoea—Etoposide—hematologic cancer	0.000165	0.000165	CcSEcCtD
Iohexol—Eye disorder—Doxorubicin—hematologic cancer	0.000165	0.000165	CcSEcCtD
Iohexol—Feeling abnormal—Betamethasone—hematologic cancer	0.000164	0.000164	CcSEcCtD
Iohexol—Feeling abnormal—Dexamethasone—hematologic cancer	0.000164	0.000164	CcSEcCtD
Iohexol—Flushing—Doxorubicin—hematologic cancer	0.000163	0.000163	CcSEcCtD
Iohexol—Cardiac disorder—Doxorubicin—hematologic cancer	0.000163	0.000163	CcSEcCtD
Iohexol—Flatulence—Epirubicin—hematologic cancer	0.000163	0.000163	CcSEcCtD
Iohexol—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000162	0.000162	CcSEcCtD
Iohexol—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000162	0.000162	CcSEcCtD
Iohexol—Dysgeusia—Epirubicin—hematologic cancer	0.000162	0.000162	CcSEcCtD
Iohexol—Hypersensitivity—Triamcinolone—hematologic cancer	0.000161	0.000161	CcSEcCtD
Iohexol—Angiopathy—Doxorubicin—hematologic cancer	0.00016	0.00016	CcSEcCtD
Iohexol—Malaise—Methotrexate—hematologic cancer	0.00016	0.00016	CcSEcCtD
Iohexol—Dizziness—Etoposide—hematologic cancer	0.00016	0.00016	CcSEcCtD
Iohexol—Muscle spasms—Epirubicin—hematologic cancer	0.000159	0.000159	CcSEcCtD
Iohexol—Immune system disorder—Doxorubicin—hematologic cancer	0.000159	0.000159	CcSEcCtD
Iohexol—Mediastinal disorder—Doxorubicin—hematologic cancer	0.000159	0.000159	CcSEcCtD
Iohexol—Urticaria—Betamethasone—hematologic cancer	0.000158	0.000158	CcSEcCtD
Iohexol—Urticaria—Dexamethasone—hematologic cancer	0.000158	0.000158	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Prednisone—hematologic cancer	0.000158	0.000158	CcSEcCtD
Iohexol—Dizziness—Prednisolone—hematologic cancer	0.000157	0.000157	CcSEcCtD
Iohexol—Arrhythmia—Doxorubicin—hematologic cancer	0.000157	0.000157	CcSEcCtD
Iohexol—Abdominal pain—Dexamethasone—hematologic cancer	0.000157	0.000157	CcSEcCtD
Iohexol—Body temperature increased—Dexamethasone—hematologic cancer	0.000157	0.000157	CcSEcCtD
Iohexol—Abdominal pain—Betamethasone—hematologic cancer	0.000157	0.000157	CcSEcCtD
Iohexol—Body temperature increased—Betamethasone—hematologic cancer	0.000157	0.000157	CcSEcCtD
Iohexol—Nausea—Cisplatin—hematologic cancer	0.000156	0.000156	CcSEcCtD
Iohexol—Paraesthesia—Prednisone—hematologic cancer	0.000155	0.000155	CcSEcCtD
Iohexol—Pruritus—Triamcinolone—hematologic cancer	0.000155	0.000155	CcSEcCtD
Iohexol—Cough—Methotrexate—hematologic cancer	0.000154	0.000154	CcSEcCtD
Iohexol—Mental disorder—Doxorubicin—hematologic cancer	0.000154	0.000154	CcSEcCtD
Iohexol—Convulsion—Methotrexate—hematologic cancer	0.000153	0.000153	CcSEcCtD
Iohexol—Vomiting—Etoposide—hematologic cancer	0.000153	0.000153	CcSEcCtD
Iohexol—Erythema—Doxorubicin—hematologic cancer	0.000153	0.000153	CcSEcCtD
Iohexol—Rash—Etoposide—hematologic cancer	0.000152	0.000152	CcSEcCtD
Iohexol—Dermatitis—Etoposide—hematologic cancer	0.000152	0.000152	CcSEcCtD
Iohexol—Headache—Etoposide—hematologic cancer	0.000151	0.000151	CcSEcCtD
Iohexol—Flatulence—Doxorubicin—hematologic cancer	0.000151	0.000151	CcSEcCtD
Iohexol—Arthralgia—Methotrexate—hematologic cancer	0.000151	0.000151	CcSEcCtD
Iohexol—Dysgeusia—Doxorubicin—hematologic cancer	0.00015	0.00015	CcSEcCtD
Iohexol—Rash—Prednisolone—hematologic cancer	0.00015	0.00015	CcSEcCtD
Iohexol—Dermatitis—Prednisolone—hematologic cancer	0.00015	0.00015	CcSEcCtD
Iohexol—Malaise—Epirubicin—hematologic cancer	0.000149	0.000149	CcSEcCtD
Iohexol—Headache—Prednisolone—hematologic cancer	0.000149	0.000149	CcSEcCtD
Iohexol—Discomfort—Methotrexate—hematologic cancer	0.000149	0.000149	CcSEcCtD
Iohexol—Syncope—Epirubicin—hematologic cancer	0.000149	0.000149	CcSEcCtD
Iohexol—Muscle spasms—Doxorubicin—hematologic cancer	0.000147	0.000147	CcSEcCtD
Iohexol—Confusional state—Methotrexate—hematologic cancer	0.000146	0.000146	CcSEcCtD
Iohexol—Loss of consciousness—Epirubicin—hematologic cancer	0.000146	0.000146	CcSEcCtD
Iohexol—Dizziness—Triamcinolone—hematologic cancer	0.000145	0.000145	CcSEcCtD
Iohexol—Cough—Epirubicin—hematologic cancer	0.000145	0.000145	CcSEcCtD
Iohexol—Anaphylactic shock—Methotrexate—hematologic cancer	0.000144	0.000144	CcSEcCtD
Iohexol—Convulsion—Epirubicin—hematologic cancer	0.000144	0.000144	CcSEcCtD
Iohexol—Nausea—Etoposide—hematologic cancer	0.000143	0.000143	CcSEcCtD
Iohexol—Hypertension—Epirubicin—hematologic cancer	0.000143	0.000143	CcSEcCtD
Iohexol—Feeling abnormal—Prednisone—hematologic cancer	0.000142	0.000142	CcSEcCtD
Iohexol—Nervous system disorder—Methotrexate—hematologic cancer	0.000142	0.000142	CcSEcCtD
Iohexol—Gastrointestinal pain—Prednisone—hematologic cancer	0.000141	0.000141	CcSEcCtD
Iohexol—Nausea—Prednisolone—hematologic cancer	0.000141	0.000141	CcSEcCtD
Iohexol—Arthralgia—Epirubicin—hematologic cancer	0.000141	0.000141	CcSEcCtD
Iohexol—Pruritus—Betamethasone—hematologic cancer	0.00014	0.00014	CcSEcCtD
Iohexol—Pruritus—Dexamethasone—hematologic cancer	0.00014	0.00014	CcSEcCtD
Iohexol—Skin disorder—Methotrexate—hematologic cancer	0.00014	0.00014	CcSEcCtD
Iohexol—Discomfort—Epirubicin—hematologic cancer	0.000139	0.000139	CcSEcCtD
Iohexol—Vomiting—Triamcinolone—hematologic cancer	0.000139	0.000139	CcSEcCtD
Iohexol—Malaise—Doxorubicin—hematologic cancer	0.000138	0.000138	CcSEcCtD
Iohexol—Rash—Triamcinolone—hematologic cancer	0.000138	0.000138	CcSEcCtD
Iohexol—Dermatitis—Triamcinolone—hematologic cancer	0.000138	0.000138	CcSEcCtD
Iohexol—Syncope—Doxorubicin—hematologic cancer	0.000137	0.000137	CcSEcCtD
Iohexol—Urticaria—Prednisone—hematologic cancer	0.000137	0.000137	CcSEcCtD
Iohexol—Headache—Triamcinolone—hematologic cancer	0.000137	0.000137	CcSEcCtD
Iohexol—Abdominal pain—Prednisone—hematologic cancer	0.000137	0.000137	CcSEcCtD
Iohexol—Body temperature increased—Prednisone—hematologic cancer	0.000137	0.000137	CcSEcCtD
Iohexol—Confusional state—Epirubicin—hematologic cancer	0.000136	0.000136	CcSEcCtD
Iohexol—Diarrhoea—Dexamethasone—hematologic cancer	0.000136	0.000136	CcSEcCtD
Iohexol—Diarrhoea—Betamethasone—hematologic cancer	0.000136	0.000136	CcSEcCtD
Iohexol—Anaphylactic shock—Epirubicin—hematologic cancer	0.000135	0.000135	CcSEcCtD
Iohexol—Hypotension—Methotrexate—hematologic cancer	0.000135	0.000135	CcSEcCtD
Iohexol—Loss of consciousness—Doxorubicin—hematologic cancer	0.000135	0.000135	CcSEcCtD
Iohexol—Cough—Doxorubicin—hematologic cancer	0.000134	0.000134	CcSEcCtD
Iohexol—Shock—Epirubicin—hematologic cancer	0.000133	0.000133	CcSEcCtD
Iohexol—Convulsion—Doxorubicin—hematologic cancer	0.000133	0.000133	CcSEcCtD
Iohexol—Nervous system disorder—Epirubicin—hematologic cancer	0.000133	0.000133	CcSEcCtD
Iohexol—Hypertension—Doxorubicin—hematologic cancer	0.000132	0.000132	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Methotrexate—hematologic cancer	0.000132	0.000132	CcSEcCtD
Iohexol—Skin disorder—Epirubicin—hematologic cancer	0.000131	0.000131	CcSEcCtD
Iohexol—Dizziness—Dexamethasone—hematologic cancer	0.000131	0.000131	CcSEcCtD
Iohexol—Dizziness—Betamethasone—hematologic cancer	0.000131	0.000131	CcSEcCtD
Iohexol—Arthralgia—Doxorubicin—hematologic cancer	0.000131	0.000131	CcSEcCtD
Iohexol—Nausea—Triamcinolone—hematologic cancer	0.00013	0.00013	CcSEcCtD
Iohexol—Paraesthesia—Methotrexate—hematologic cancer	0.00013	0.00013	CcSEcCtD
Iohexol—Discomfort—Doxorubicin—hematologic cancer	0.000129	0.000129	CcSEcCtD
Iohexol—Dyspnoea—Methotrexate—hematologic cancer	0.000129	0.000129	CcSEcCtD
Iohexol—Somnolence—Methotrexate—hematologic cancer	0.000128	0.000128	CcSEcCtD
Iohexol—Hypersensitivity—Prednisone—hematologic cancer	0.000127	0.000127	CcSEcCtD
Iohexol—Hypotension—Epirubicin—hematologic cancer	0.000126	0.000126	CcSEcCtD
Iohexol—Vomiting—Dexamethasone—hematologic cancer	0.000126	0.000126	CcSEcCtD
Iohexol—Vomiting—Betamethasone—hematologic cancer	0.000126	0.000126	CcSEcCtD
Iohexol—Confusional state—Doxorubicin—hematologic cancer	0.000126	0.000126	CcSEcCtD
Iohexol—Rash—Dexamethasone—hematologic cancer	0.000125	0.000125	CcSEcCtD
Iohexol—Rash—Betamethasone—hematologic cancer	0.000125	0.000125	CcSEcCtD
Iohexol—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000125	0.000125	CcSEcCtD
Iohexol—Dermatitis—Betamethasone—hematologic cancer	0.000125	0.000125	CcSEcCtD
Iohexol—Dermatitis—Dexamethasone—hematologic cancer	0.000125	0.000125	CcSEcCtD
Iohexol—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.000125	0.000125	CcSEcCtD
Iohexol—Headache—Betamethasone—hematologic cancer	0.000124	0.000124	CcSEcCtD
Iohexol—Headache—Dexamethasone—hematologic cancer	0.000124	0.000124	CcSEcCtD
Iohexol—Pain—Methotrexate—hematologic cancer	0.000124	0.000124	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Epirubicin—hematologic cancer	0.000123	0.000123	CcSEcCtD
Iohexol—Shock—Doxorubicin—hematologic cancer	0.000123	0.000123	CcSEcCtD
Iohexol—Nervous system disorder—Doxorubicin—hematologic cancer	0.000123	0.000123	CcSEcCtD
Iohexol—Pruritus—Prednisone—hematologic cancer	0.000122	0.000122	CcSEcCtD
Iohexol—Skin disorder—Doxorubicin—hematologic cancer	0.000122	0.000122	CcSEcCtD
Iohexol—Paraesthesia—Epirubicin—hematologic cancer	0.000121	0.000121	CcSEcCtD
Iohexol—Dyspnoea—Epirubicin—hematologic cancer	0.000121	0.000121	CcSEcCtD
Iohexol—Somnolence—Epirubicin—hematologic cancer	0.00012	0.00012	CcSEcCtD
Iohexol—Feeling abnormal—Methotrexate—hematologic cancer	0.000119	0.000119	CcSEcCtD
Iohexol—Diarrhoea—Prednisone—hematologic cancer	0.000118	0.000118	CcSEcCtD
Iohexol—Gastrointestinal pain—Methotrexate—hematologic cancer	0.000118	0.000118	CcSEcCtD
Iohexol—Nausea—Dexamethasone—hematologic cancer	0.000118	0.000118	CcSEcCtD
Iohexol—Nausea—Betamethasone—hematologic cancer	0.000118	0.000118	CcSEcCtD
Iohexol—Hypotension—Doxorubicin—hematologic cancer	0.000117	0.000117	CcSEcCtD
Iohexol—Gastrointestinal disorder—Epirubicin—hematologic cancer	0.000117	0.000117	CcSEcCtD
Iohexol—Pain—Epirubicin—hematologic cancer	0.000116	0.000116	CcSEcCtD
Iohexol—Urticaria—Methotrexate—hematologic cancer	0.000115	0.000115	CcSEcCtD
Iohexol—Dizziness—Prednisone—hematologic cancer	0.000114	0.000114	CcSEcCtD
Iohexol—Body temperature increased—Methotrexate—hematologic cancer	0.000114	0.000114	CcSEcCtD
Iohexol—Abdominal pain—Methotrexate—hematologic cancer	0.000114	0.000114	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	0.000114	0.000114	CcSEcCtD
Iohexol—Paraesthesia—Doxorubicin—hematologic cancer	0.000112	0.000112	CcSEcCtD
Iohexol—Dyspnoea—Doxorubicin—hematologic cancer	0.000112	0.000112	CcSEcCtD
Iohexol—Feeling abnormal—Epirubicin—hematologic cancer	0.000111	0.000111	CcSEcCtD
Iohexol—Somnolence—Doxorubicin—hematologic cancer	0.000111	0.000111	CcSEcCtD
Iohexol—Gastrointestinal pain—Epirubicin—hematologic cancer	0.000111	0.000111	CcSEcCtD
Iohexol—Vomiting—Prednisone—hematologic cancer	0.00011	0.00011	CcSEcCtD
Iohexol—Rash—Prednisone—hematologic cancer	0.000109	0.000109	CcSEcCtD
Iohexol—Dermatitis—Prednisone—hematologic cancer	0.000109	0.000109	CcSEcCtD
Iohexol—Headache—Prednisone—hematologic cancer	0.000108	0.000108	CcSEcCtD
Iohexol—Gastrointestinal disorder—Doxorubicin—hematologic cancer	0.000108	0.000108	CcSEcCtD
Iohexol—Urticaria—Epirubicin—hematologic cancer	0.000107	0.000107	CcSEcCtD
Iohexol—Pain—Doxorubicin—hematologic cancer	0.000107	0.000107	CcSEcCtD
Iohexol—Body temperature increased—Epirubicin—hematologic cancer	0.000107	0.000107	CcSEcCtD
Iohexol—Abdominal pain—Epirubicin—hematologic cancer	0.000107	0.000107	CcSEcCtD
Iohexol—Hypersensitivity—Methotrexate—hematologic cancer	0.000106	0.000106	CcSEcCtD
Iohexol—Feeling abnormal—Doxorubicin—hematologic cancer	0.000103	0.000103	CcSEcCtD
Iohexol—Nausea—Prednisone—hematologic cancer	0.000103	0.000103	CcSEcCtD
Iohexol—Gastrointestinal pain—Doxorubicin—hematologic cancer	0.000102	0.000102	CcSEcCtD
Iohexol—Pruritus—Methotrexate—hematologic cancer	0.000102	0.000102	CcSEcCtD
Iohexol—Hypersensitivity—Epirubicin—hematologic cancer	9.96e-05	9.96e-05	CcSEcCtD
Iohexol—Urticaria—Doxorubicin—hematologic cancer	9.94e-05	9.94e-05	CcSEcCtD
Iohexol—Abdominal pain—Doxorubicin—hematologic cancer	9.89e-05	9.89e-05	CcSEcCtD
Iohexol—Body temperature increased—Doxorubicin—hematologic cancer	9.89e-05	9.89e-05	CcSEcCtD
Iohexol—Diarrhoea—Methotrexate—hematologic cancer	9.89e-05	9.89e-05	CcSEcCtD
Iohexol—Pruritus—Epirubicin—hematologic cancer	9.57e-05	9.57e-05	CcSEcCtD
Iohexol—Dizziness—Methotrexate—hematologic cancer	9.56e-05	9.56e-05	CcSEcCtD
Iohexol—Diarrhoea—Epirubicin—hematologic cancer	9.25e-05	9.25e-05	CcSEcCtD
Iohexol—Hypersensitivity—Doxorubicin—hematologic cancer	9.22e-05	9.22e-05	CcSEcCtD
Iohexol—Vomiting—Methotrexate—hematologic cancer	9.19e-05	9.19e-05	CcSEcCtD
Iohexol—Rash—Methotrexate—hematologic cancer	9.11e-05	9.11e-05	CcSEcCtD
Iohexol—Dermatitis—Methotrexate—hematologic cancer	9.1e-05	9.1e-05	CcSEcCtD
Iohexol—Headache—Methotrexate—hematologic cancer	9.05e-05	9.05e-05	CcSEcCtD
Iohexol—Dizziness—Epirubicin—hematologic cancer	8.94e-05	8.94e-05	CcSEcCtD
Iohexol—Pruritus—Doxorubicin—hematologic cancer	8.85e-05	8.85e-05	CcSEcCtD
Iohexol—Vomiting—Epirubicin—hematologic cancer	8.6e-05	8.6e-05	CcSEcCtD
Iohexol—Nausea—Methotrexate—hematologic cancer	8.58e-05	8.58e-05	CcSEcCtD
Iohexol—Diarrhoea—Doxorubicin—hematologic cancer	8.56e-05	8.56e-05	CcSEcCtD
Iohexol—Rash—Epirubicin—hematologic cancer	8.53e-05	8.53e-05	CcSEcCtD
Iohexol—Dermatitis—Epirubicin—hematologic cancer	8.52e-05	8.52e-05	CcSEcCtD
Iohexol—Headache—Epirubicin—hematologic cancer	8.47e-05	8.47e-05	CcSEcCtD
Iohexol—Dizziness—Doxorubicin—hematologic cancer	8.27e-05	8.27e-05	CcSEcCtD
Iohexol—Nausea—Epirubicin—hematologic cancer	8.03e-05	8.03e-05	CcSEcCtD
Iohexol—Vomiting—Doxorubicin—hematologic cancer	7.96e-05	7.96e-05	CcSEcCtD
Iohexol—Rash—Doxorubicin—hematologic cancer	7.89e-05	7.89e-05	CcSEcCtD
Iohexol—Dermatitis—Doxorubicin—hematologic cancer	7.88e-05	7.88e-05	CcSEcCtD
Iohexol—Headache—Doxorubicin—hematologic cancer	7.84e-05	7.84e-05	CcSEcCtD
Iohexol—Nausea—Doxorubicin—hematologic cancer	7.43e-05	7.43e-05	CcSEcCtD
